These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8475632)

  • 1. [Metabolic syndrome--bridge to type II diabetes].
    Häring HU
    Z Gesamte Inn Med; 1993 Mar; 48(3):108-11. PubMed ID: 8475632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiologic principles of metabolic syndrome. Consequences for early diagnosis and prevention].
    Häring HU
    Fortschr Med; 1992 Dec; 110(34):633-6. PubMed ID: 1483614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid metabolism and insulin resistance--clinical aspects and pathobiochemistry].
    Gries FA; Hübinger A
    Wien Klin Wochenschr; 1994; 106(24):763-7. PubMed ID: 7846895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
    Rett K; Wicklmayr M; Standl E
    Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology of insulin resistance].
    Häring H
    Herz; 1995 Feb; 20(1):5-15. PubMed ID: 7713477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiologic basis for obesity in diabetes type II].
    Czech A; Bernas M; Tatoń J
    Pol Tyg Lek; 1995; Suppl 1():37-40. PubMed ID: 7596907
    [No Abstract]   [Full Text] [Related]  

  • 8. A role for suppressed skeletal muscle thermogenesis in pathways from weight fluctuations to the insulin resistance syndrome.
    Dulloo AG
    Acta Physiol Scand; 2005 Aug; 184(4):295-307. PubMed ID: 16026421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and steatosis in humans.
    Capeau J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
    Smith AG; Muscat GE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
    Salmenniemi U; Ruotsalainen E; Pihlajamäki J; Vauhkonen I; Kainulainen S; Punnonen K; Vanninen E; Laakso M
    Circulation; 2004 Dec; 110(25):3842-8. PubMed ID: 15596567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and its impact on the approach to therapy of type 2 diabetes.
    Laakso M
    Int J Clin Pract Suppl; 2001 Sep; (121):8-12. PubMed ID: 11594246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension in metabolic syndrome. Etiology and consequences].
    Rett K
    Fortschr Med; 1992 Dec; 110(34):642-4. PubMed ID: 1483616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.